
Patrick M. Buechner
Examiner (ID: 14872, Phone: (571)270-5171 , Office: P/3754 )
| Most Active Art Unit | 3754 |
| Art Unit(s) | 3799, 3754, OPQA |
| Total Applications | 1001 |
| Issued Applications | 780 |
| Pending Applications | 36 |
| Abandoned Applications | 187 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16839423
[patent_doc_number] => 20210147435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => COMPOUNDS, COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/637718
[patent_app_country] => US
[patent_app_date] => 2018-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16637718
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/637718 | Modulators of eukaryotic initiation factor 2B, compositions and methods | Aug 7, 2018 | Issued |
Array
(
[id] => 17407110
[patent_doc_number] => 11247979
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Method for the preparation of thiocarbonates
[patent_app_type] => utility
[patent_app_number] => 16/634230
[patent_app_country] => US
[patent_app_date] => 2018-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7127
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16634230
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/634230 | Method for the preparation of thiocarbonates | Aug 6, 2018 | Issued |
Array
(
[id] => 18748312
[patent_doc_number] => 11807608
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Polymerizable compounds with one or more surfactant-like properties
[patent_app_type] => utility
[patent_app_number] => 16/635523
[patent_app_country] => US
[patent_app_date] => 2018-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 10428
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635523
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635523 | Polymerizable compounds with one or more surfactant-like properties | Jul 30, 2018 | Issued |
Array
(
[id] => 16468158
[patent_doc_number] => 20200369695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => ORGANOPHOSPHATE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/635469
[patent_app_country] => US
[patent_app_date] => 2018-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635469 | Organophosphate derivatives | Jul 29, 2018 | Issued |
Array
(
[id] => 14534347
[patent_doc_number] => 20190202795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/046254
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16046254
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/046254 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | Jul 25, 2018 | Abandoned |
Array
(
[id] => 14467641
[patent_doc_number] => 20190185463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/046268
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16046268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/046268 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | Jul 25, 2018 | Abandoned |
Array
(
[id] => 14578391
[patent_doc_number] => 20190216804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/039403
[patent_app_country] => US
[patent_app_date] => 2018-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16039403
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/039403 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS | Jul 18, 2018 | Abandoned |
Array
(
[id] => 13826401
[patent_doc_number] => 20190016685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => 1,3-DIAZA-SPIRO-[3.4]-OCTANE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/033446
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16033446
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/033446 | 1,3-DIAZA-SPIRO-[3.4]-OCTANE DERIVATIVES | Jul 11, 2018 | Abandoned |
Array
(
[id] => 14029407
[patent_doc_number] => 10226434
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity
[patent_app_type] => utility
[patent_app_number] => 16/025284
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7233
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025284
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/025284 | Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity | Jul 1, 2018 | Issued |
Array
(
[id] => 14518927
[patent_doc_number] => 10336710
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Benzimidazole derivatives, preparation method therefor, and applications thereof
[patent_app_type] => utility
[patent_app_number] => 16/015227
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9732
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16015227
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/015227 | Benzimidazole derivatives, preparation method therefor, and applications thereof | Jun 21, 2018 | Issued |
Array
(
[id] => 16955969
[patent_doc_number] => 11059809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Substituted cyanopyrrolidines with activity as DUB inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/615709
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11719
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615709
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615709 | Substituted cyanopyrrolidines with activity as DUB inhibitors | Jun 18, 2018 | Issued |
Array
(
[id] => 16839428
[patent_doc_number] => 20210147440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => METHODS FOR THE PREPARATION OF 1,3-BENZODIOXOLE HETEROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/624491
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16624491
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/624491 | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds | Jun 18, 2018 | Issued |
Array
(
[id] => 14198825
[patent_doc_number] => 10266505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Compositions and methods for treating cancers
[patent_app_type] => utility
[patent_app_number] => 16/012536
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 25
[patent_no_of_words] => 29516
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16012536
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/012536 | Compositions and methods for treating cancers | Jun 18, 2018 | Issued |
Array
(
[id] => 13621959
[patent_doc_number] => 20180362531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => NOVEL KYNUREININE PATHWAY INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/011432
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6384
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011432
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/011432 | NOVEL KYNUREININE PATHWAY INHIBITORS | Jun 17, 2018 | Abandoned |
Array
(
[id] => 13589815
[patent_doc_number] => 20180346456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => SMALL MOLECULE AGONISTS AND ANTAGONISTS OF NR2F6 ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/008526
[patent_app_country] => US
[patent_app_date] => 2018-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16008526
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/008526 | Small molecule agonists and antagonists of NR2F6 activity | Jun 13, 2018 | Issued |
Array
(
[id] => 13478985
[patent_doc_number] => 20180291035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => MYC MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/005455
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -88
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16005455
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/005455 | MYC MODULATORS AND USES THEREOF | Jun 10, 2018 | Abandoned |
Array
(
[id] => 13478985
[patent_doc_number] => 20180291035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => MYC MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/005455
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -88
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16005455
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/005455 | MYC MODULATORS AND USES THEREOF | Jun 10, 2018 | Abandoned |
Array
(
[id] => 13478895
[patent_doc_number] => 20180290990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => DESFERRITHIOCIN POLYETHER ANALOGUES
[patent_app_type] => utility
[patent_app_number] => 16/005483
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16005483
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/005483 | DESFERRITHIOCIN POLYETHER ANALOGUES | Jun 10, 2018 | Abandoned |
Array
(
[id] => 13440601
[patent_doc_number] => 20180271843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => HISTONE DEMETHYLASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/996316
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996316
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996316 | Histone demethylase inhibitors | May 31, 2018 | Issued |
Array
(
[id] => 13589795
[patent_doc_number] => 20180346446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => IRE1 SMALL MOLECULE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/994901
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994901
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/994901 | IRE1 SMALL MOLECULE INHIBITORS | May 30, 2018 | Abandoned |